Avery Pharmaceutical’s manufacturing capabilities are fueled by AGTL’s technologically-advanced infrastructure – a pharmaceutical-focused manufacturing setup that conforms to globally approved practices.
As a result, each of Avery’s products comes with the assurance of having undergone multiple quality checks and their performance is well documented, with exhaustive research data.
Avery Pharmaceutical’s manufacturing capabilities are fueled by AGTL’s technologically-advanced infrastructure – a pharmaceutical-focused manufacturing setup that conforms to globally approved practices.
As a result, each of Avery’s products comes with the assurance of having undergone multiple quality checks and their performance is well documented, with exhaustive research data.
State-of-the-art manufacturing unit at Ahmedabad, Gujarat, India. Fully integrated infrastructure spread over 26,000 square feet. Dedicated laboratories for formulation development, quality analysis, and quality control.
Complying with regulatory authorities for ethical manufacturing processes. Maximum support for contract manufacturing. Greater transparency for 3rd-party manufacturing projects. Specialized, Quality Control & Quality Assurance teams.
State-of-the-art manufacturing unit at Ahmedabad, Gujarat, India. Fully integrated infrastructure spread over 26,000 square feet. Dedicated laboratories for formulation development, quality analysis, and quality control.
Complying with regulatory authorities for ethical manufacturing processes. Maximum support for contract manufacturing. Greater transparency for 3rd-party manufacturing projects. Specialized, Quality Control & Quality Assurance teams.
Quality standards remain the primary governing factor, embedded across the MDS development process at Avery Pharmaceuticals. We are committed to constantly testing and improving every aspect of our drug delivery technology. We adhere to intensive, in-house testing. The in-house SOPs have been developed in-sync with the strictest regulatory norms.
We are also getting more international accreditation. From patenting, to regulatory global filings to developing dossiers, profiling complex chemistry, and clinical trials, quality-focused standards are not relaxed at any stage.
Quality standards remain the primary governing factor, embedded across the MDS development process at Avery Pharmaceuticals. We are committed to constantly testing and improving every aspect of our drug delivery technology. We adhere to intensive, in-house testing. The in-house SOPs have been developed in-sync with the strictest regulatory norms.
We are also getting more international accreditation. From patenting, to regulatory global filings to developing dossiers, profiling complex chemistry, and clinical trials, quality-focused standards are not relaxed at any stage.
